☰

Emanuela I. Sega, Ph.D. - Publications

Affiliations: 
2006 Purdue University, West Lafayette, IN, United States 
Area:
ligand-targeted imaging and therapeutic agents for the diagnosis and treatment of important human diseases
Tree Info Similar researchers PubMed Report error

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Etxeberria I, Bolaños E, Teijeira A, Garasa S, Yanguas A, Azpilikueta A, Kavanaugh WM, Vasiljeva O, Belvin M, Howng B, Irving B, Tipton K, West J, Mei L, Korman AJ, ... Sega E, et al. Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34172583 DOI: 10.1073/pnas.2025930118  0.347
2014 Florek M, Sega EI, Leveson-Gower DB, Baker J, Müller AM, Schneidawind D, Meyer E, Negrin RS. Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models. Blood. 124: 1832-42. PMID 25030062 DOI: 10.1182/Blood-2014-02-555128  0.457
2014 Sega EI, Leveson-Gower DB, Florek M, Schneidawind D, Luong RH, Negrin RS. Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantation. Plos One. 9: e86551. PMID 24475140 DOI: 10.1371/Journal.Pone.0086551  0.467
2013 Leveson-Gower DB, Sega EI, Kalesnikoff J, Florek M, Pan Y, Pierini A, Galli SJ, Negrin RS. Mast cells suppress murine GVHD in a mechanism independent of CD4+CD25+ regulatory T cells. Blood. 122: 3659-65. PMID 24030387 DOI: 10.1182/Blood-2013-08-519157  0.468
2013 Colonna L, Florek M, Leveson-Gower DB, Sega EI, Baker J, Smith AT, Negrin RS. IL-17 gene ablation does not impact Treg-mediated suppression of graft-versus-host disease after bone marrow transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1557-65. PMID 23921175 DOI: 10.1016/J.Bbmt.2013.07.024  0.439
2012 Florek M, Sega E, Mueller A, Leveson-Gower D, Shizuru J, Negrin R. Infusion of Syngeneic Apoptotic Cells Prior to Bone Marrow Transplantation Decreases Tcell Proliferation and Increases Survival Biology of Blood and Marrow Transplantation. 18: S221. DOI: 10.1016/J.Bbmt.2011.12.054  0.341
2011 Shin HJ, Baker J, Leveson-Gower DB, Smith AT, Sega EI, Negrin RS. Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells. Blood. 118: 2342-50. PMID 21734238 DOI: 10.1182/Blood-2010-10-313684  0.411
2011 Leveson-Gower DB, Olson JA, Sega EI, Luong RH, Baker J, Zeiser R, Negrin RS. Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism. Blood. 117: 3220-9. PMID 21258007 DOI: 10.1182/Blood-2010-08-303008  0.541
2011 Colonna L, Sega EI, Negrin RS. Natural and expanded CD4(+)CD25(+) regulatory T cells in bone marrow transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: S58-62. PMID 21195311 DOI: 10.1016/J.Bbmt.2010.10.020  0.478
2011 Colonna L, Florek M, Leveson-Gower DB, Sega EI, Zeiser R, Buess M, Negrin RS. IL-17 Gene Ablation Does Not Impact Treg-Mediated Suppression of Graft-Versus-Host Disease Following Bone Marrow Transplantation, Blood. 118: 4037-4037. DOI: 10.1182/Blood.V118.21.4037.4037  0.483
2011 Florek M, Sega EI, Mueller AM, Leveson-Gower DB, Shizuru JA, Negrin RS. A Novel Model of Pre-Emptive ECP Treatment Shows Significant Reduction of Gvhd-Related Mortality In Mice, Blood. 118: 4025-4025. DOI: 10.1182/Blood.V118.21.4025.4025  0.448
2011 Sega EI, Leveson-Gower DB, Florek M, Negrin RS. The Inhibitory Receptor LAG-3 Is Not Essential for Regulatory T Cells Function but Influences Donor T Cell Potency in Acute Graft-Versus-Host-Disease Blood. 118: 1900-1900. DOI: 10.1182/Blood.V118.21.1900.1900  0.421
2011 Florek M, Sega EI, Leveson-Gower DB, Gill S, Mueller AMS, Negrin RS. Single Dose Administration of ECP Treated Cells Prior to Transplantation Significantly Increases Survival in a MHC-Mismatched Model of Acute GvHD Biology of Blood and Marrow Transplantation. 17. DOI: 10.1016/J.Bbmt.2010.12.552  0.349
2011 Leveson-Gower D, Sega E, Kalesnikoff J, Florek M, Galli S, Negrin R. Mast Cells Suppress GVHD in a Mechanism Independent of CD4+CD25+ Regulatory T Cells Biology of Blood and Marrow Transplantation. 17: S328. DOI: 10.1016/J.Bbmt.2010.12.524  0.412
2010 Leveson-Gower DB, Sega EI, Kalesnikoff J, Florek M, Galli SJ, Negrin R. Mast Cells Reduce Gvhd Severity In Allogeneic Transplantation by Reducing the Proliferation of Conventional T Cells Blood. 116: 243-243. DOI: 10.1182/Blood.V116.21.243.243  0.506
2010 Sega EI, Leveson-Gower D, Nguyen VH, Negrin RS. Ex-Vivo Expanded And Freshly Isolated CD4+CD25+FOXP3+ Regulatory T Cells Suppress Murine Acute GVHD With Different Potency Biology of Blood and Marrow Transplantation. 16. DOI: 10.1016/J.Bbmt.2009.12.036  0.384
2009 Leveson-Gower D, Olson J, Sega EI, Baker J, Zeiser R, Negrin R. Gvhd Severity Is Regulated by the Adoptive Transfer Low Numbers of NKT Cells by a Mechanism Distinct From CD4+CD25+ Regulatory T Cells. Blood. 114: 229-229. DOI: 10.1182/Blood.V114.22.229.229  0.469
2009 Shin H, Baker J, Leveson-Gower D, Sega EI, Negrin R. Rapamycin and IL-2 Prevents Lethal Acute Graft-Versus Host Disease by Expansion of Donor Type CD4+CD25+Foxp3+ Regulatory T Cells. Blood. 114: 1334-1334. DOI: 10.1182/Blood.V114.22.1334.1334  0.424
2009 Leveson-Gower D, Olson J, Sega E, Baker J, Zeiser R, Negrin R. Adoptive Transfer of NKT Cells Reduces GVHD Severity Via an IFN-γ And IL-4 Dependent Mechanism Biology of Blood and Marrow Transplantation. 15: 13. DOI: 10.1016/J.Bbmt.2008.12.037  0.35
2008 Nishimura R, Baker J, Beilhack A, Zeiser R, Olson JA, Sega EI, Karimi M, Negrin RS. In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity. Blood. 112: 2563-74. PMID 18565854 DOI: 10.1182/Blood-2007-06-092817  0.532
2008 Sega EI, Low PS. Tumor detection using folate receptor-targeted imaging agents. Cancer Metastasis Reviews. 27: 655-64. PMID 18523731 DOI: 10.1007/S10555-008-9155-6  0.51
2008 Sega EI, Lu Y, Ringor M, Leamon CP, Low PS. Low-dose radiation potentiates the therapeutic efficacy of folate receptor-targeted hapten therapy. International Journal of Radiation Oncology, Biology, Physics. 71: 559-66. PMID 18411004 DOI: 10.1016/J.Ijrobp.2008.02.010  0.595
2008 Zhang K, Wang Q, Xie Y, Mor G, Sega E, Low PS, Huang Y. Receptor-mediated delivery of siRNAs by tethered nucleic acid base-paired interactions. Rna (New York, N.Y.). 14: 577-83. PMID 18218703 DOI: 10.1261/Rna.739308  0.515
2008 Sega EI, Leveson-Gower D, Nguyen VH, Negrin R. Functional Comparison of Freshly Isolated and Ex-Vivo Expanded CD4+CD25+Foxp3+ Regulatory T Cells in Suppressing Murine Acute GvHD Blood. 112: 812-812. DOI: 10.1182/Blood.V112.11.812.812  0.485
2006 Lu Y, Yang J, Sega E. Issues related to targeted delivery of proteins and peptides. The Aaps Journal. 8: E466-78. PMID 17025264 DOI: 10.1208/Aapsj080355  0.44
2005 Lu Y, Sega E, Low PS. Folate receptor-targeted immunotherapy: induction of humoral and cellular immunity against hapten-decorated cancer cells. International Journal of Cancer. Journal International Du Cancer. 116: 710-9. PMID 15828051 DOI: 10.1002/Ijc.21126  0.659
2004 Lu Y, Sega E, Leamon CP, Low PS. Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential. Advanced Drug Delivery Reviews. 56: 1161-76. PMID 15094213 DOI: 10.1016/J.Addr.2004.01.009  0.636
Show low-probability matches.